Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07010159 · ClinicalTrials.gov registry record · Phase 2
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
A Phase 2 study of Recurrent Pericarditis and Pericarditis, sponsored by Kiniksa Pharmaceuticals International.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 165
- Enrollment target
- 20
- Study locations
NCT07010159: Recruiting Phase 2 study of Recurrent Pericarditis and Pericarditis, sponsored by Kiniksa Pharmaceuticals International.
NCT07010159 is a Phase 2 study of Recurrent Pericarditis and Pericarditis that is actively recruiting participants, run by Kiniksa Pharmaceuticals International. The registered enrollment target is 165 participants, below the 185-participant average among 4 other Recurrent Pericarditis trials with a reported enrollment target (11% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07010159, a Phase 2 study of Recurrent Pericarditis and Pericarditis, is actively recruiting participants, sponsored by Kiniksa Pharmaceuticals International.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 165 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is being done to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG KPL-387
Study Locations (20)
California
- Investigational Site 030 - Los Angeles
- Investigational Site 008 - San Francisco
New York
- Investigational Site 015 - New York
- Investigational Site 022 - New York
Ohio
- Investigational Site 009 - Cincinnati
- Investigational Site 003 - Cleveland
Texas
- Investigational Site 005 - Austin
- Investigational Site 013 - Houston
Virginia
- Investigational Site 006 - Charlottesville
- Investigational Site 023 - Norfolk
Other
- Investigational Site 028 - Montpellier
- Investigational Site 021 - Paris
Arizona
- Investigational Site 018 - Gilbert
Colorado
- Investigational Site 016 - Westminster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2025-07-25 |
| Est. Completion | 2029-12-31 |
| Phase | Phase 2 |
What NCT07010159 shows while recruiting
NCT07010159 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 185-participant average among 4 other Recurrent Pericarditis trials with a reported enrollment target (11% lower).
The record links to 3 conditions, with Recurrent Pericarditis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07010159 names 20 study sites across 14 states, led by California, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT07010159 about?
NCT07010159 is a clinical study titled "Phase 2/3 Study of KPL-387 in Recurrent Pericarditis". This study is being done to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis.
What is the current status of trial NCT07010159?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 165 participants. The study started on 2025-07-25. Estimated completion is 2029-12-31.
What conditions does trial NCT07010159 study?
This clinical trial studies the following conditions: Recurrent Pericarditis, Pericarditis, Pericarditis Acute.
What interventions are being tested in trial NCT07010159?
The interventions under investigation include: Placebo (DRUG), KPL-387 (DRUG).
Who is sponsoring clinical trial NCT07010159?
This trial is sponsored by Kiniksa Pharmaceuticals International, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07010159 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Pericarditis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transition to KPL-387 Monotherapy Dosing & Administration Study
RECRUITING · Phase 2
-
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
RECRUITING · Phase 2
-
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
RECRUITING · Phase 3
-
REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02387255 · 165 participants
Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms
- NCT03351348 · 165 participants · Phase 3
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control
- NCT03830320 · 165 participants · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
- NCT04289571 · 165 participants · Phase 1
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI